Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: Single center experience.

Serkan AsilBarış KayaUğur CanpolatHikmet YorgunLevent ŞahinerCem ÇöteliAnıl AratKudret Aytemir

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)

In conclusion, our small-sized preliminary study results showed that septal reduction therapy using EVOH is an effective alternative option in reducing symptoms and LVOT gradient in HOCM.

Keyphrases

heart failure
hypertrophic cardiomyopathy
left ventricular
replacement therapy